Consumer articles about over-the-counter and prescription drugs.
Similar Posts
FDA Listing of Authorized Generics
FDA Listing of Authorized GenericsByHeart Inc. dba BlendHouse Allerton. Allerton, IA. EIR issued 01/30/2024
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 01/30/2024
Short Title (70 char) ByHeart Inc. dba BlendHouse Allerton. Allerton, IA. EIR issued 01/30/2024
FEI Number 1921383
Firm Name ByHeart Inc. dba BlendHouse Allerton
Record Type EIR
State IA
EstablishmentPotential Risks with Certain Uses of Radiofrequency (RF) Microneedling – FDA Safety Communication
FDA is aware of serious complications reported with certain uses of radiofrequency microneedling devices; asks for reports of injuries related these devicesDr. Reddy’s Laboratories Limited | 12/12/2025 | 483
Dr. Reddy’s Laboratories Limited | 12/12/2025 | 4832022 Meeting Materials, Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)
2022 Meeting Materials, Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee)Otsuka ICU Medical LLC Issues Voluntary Nationwide Recall of 20 mEq Potassium Chloride Injection Due To Overwrap Mislabeled As 10 mEq Potassium Chloride Injection
FOR IMMEDIATE RELEASE – October 31, 2025 AUSTIN, TX – Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELLED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The OVERWRAP label of lot 1030613, Expiration Date: 09-30-2026 may incorrectly identify the product